PmHS2 Enzyme Mutations for Heparosan Synthesis
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods face challenges in synthesizing heparan sulfate (HS) due to its diverse chemical space, low synthetic efficiency, and difficulty in producing homogenous, structurally defined HS, which limits understanding of its biological role and therapeutic possibilities.
Innovation Solution
Development of truncated Pasteurella multocida heparosan synthase 2 (PmHS2) variants with improved thermal stability and expression levels, allowing for gram-scale synthesis of heparosan oligosaccharides and reducing reverse glycosylation activities to minimize byproduct formation, thereby enhancing the synthesis of heparin and heparan sulfate analogs.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If wild-type PmHS2 is used for heparosan synthesis, then the enzyme has native catalytic activity, but the expression level is low and thermal stability is insufficient
Solution Approach 1:
The patent applies parameter changes by introducing specific point mutations (D222N and D500N) into the PmHS2 enzyme sequence to alter its physical-chemical properties. These mutations change the amino acid composition at critical positions, thereby improving thermal stability and expression levels while maintaining catalytic function. This directly resolves the contradiction between native activity and improved stability/expression.
Solution Approach 2:
The patent creates modified copies of the PmHS2 enzyme through site-directed mutagenesis. Instead of using the wild-type sequence, engineered variants with specific mutations are produced. These copied versions retain the core catalytic function while incorporating improvements in stability and expression, effectively copying the essential function while eliminating the weaknesses of the original.
2Productivity
If wild-type PmHS2 is used for oligosaccharide synthesis, then catalytic activity is maintained, but reverse glycosylation occurs leading to byproduct formation
Solution Approach 1:
The patent uses parameter changes by mutating specific residues (D222N and D500N) that are involved in the reverse glycosylation mechanism. These changes alter the enzymatic parameters to favor forward glycosylation while suppressing the reverse reaction. The mutations modify the catalytic properties to prevent byproduct formation, thereby improving synthetic efficiency by eliminating the harmful reverse glycosylation pathway.
Solution Approach 2:
The patent converts the harmful reverse glycosylation activity into a benefit by strategically mutating residues that participate in this side reaction. The mutations effectively disable the reverse glycosylation pathway, transforming a source of byproducts into an opportunity for improved product purity and yield. The enzyme is engineered to exclusively perform forward glycosylation, eliminating the harmful effect.
3Adaptability or versatility
If conventional synthesis methods are used for heparan sulfate, then the process is simple, but the chemical space diversity is limited and homogeneity is difficult to achieve
Solution Approach 1:
The patent applies local quality by using the engineered PmHS2 enzyme to perform site-specific glycosylation reactions. The enzyme catalyzes the formation of specific glycosidic bonds with precise stereochemistry and regiochemistry, ensuring uniform structure at each position. This localized precision in bond formation, controlled by the enzyme's active site geometry, achieves structural homogeneity while allowing diversity through controlled variation in substrate inputs.
Solution Approach 2:
The patent utilizes parameter changes in the enzymatic reaction conditions and substrate design to expand chemical space diversity. By varying the nucleotide sugar donors, acceptor substrates, and reaction parameters while maintaining enzymatic catalysis, a wide range of structurally defined oligosaccharides can be synthesized. The enzyme's specificity ensures that each variation produces a homogeneous product, resolving the contradiction between diversity and homogeneity.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The PmHS2 variants enable efficient synthesis of heparosan oligosaccharides up to hexasaccharides with improved stability and yield, and by minimizing reverse glycosylation, they facilitate the production of longer heparin and heparan sulfate analogs with reduced byproduct formation.
Implementation Method 1
PmHS2 is a bifunctional glycosyltransferase that catalyzes the transfer of both N-acetylglucosamine (GlcNAc) and glucuronic acid (GlcA) from their corresponding sugar nucleotides
Data Source
AI summary
Heparosan synthase variants having improved expression levels, enhanced thermal stability, and/or reduced reverse glycosylation activity are provided. Methods for making oligosaccharides and polysaccharides, including heparin analogs and heparan sulfate analogs, are also described.